EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pheton Holdings's enterprise value is $87.43 Mil.
Pheton Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.66 Mil. Therefore, Pheton Holdings's EV-to-EBITDA for today is -132.06.
The historical rank and industry rank for Pheton Holdings's EV-to-EBITDA or its related term are showing as below:
PTHL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -202.54 Med: -97.1 Max: -32.56
Current: -132.06
During the past 4 years, the highest EV-to-EBITDA of Pheton Holdings was -32.56. The lowest was -202.54. And the median was -97.10.
PTHL's EV-to-EBITDA is ranked worse than 100% of 494
companies
in the Medical Devices & Instruments industry
Industry Median: 15.425
vs PTHL: -132.06
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Pheton Holdings EV-to-EBITDA Historical Data
The historical data trend for Pheton Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pheton Holdings's EV-to-EBITDA
For the Medical Devices subindustry, Pheton Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pheton Holdings's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pheton Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Pheton Holdings's EV-to-EBITDA falls into.
Pheton Holdings's current Enterprise Value is $87.43 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pheton Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Pheton Holdings's PE Ratio (TTM) for today is calculated as:
Pheton Holdings's share price for today is $6.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pheton Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.046.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Pheton Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PTHL has been successfully added to your